From our study it seems that regardless of upregulation or downregulation of these functional genes, the trend of the tumor is to deteriorate due to the abnormal expression of genes mediated by HIF-1alpha. Our work aims to find more novel functional genes whose expression is mediated by HIF-1alpha
to support the development of new therapeutic targets for gene targeted therapy of SCLC. Acknowledgements This work was supported by the Key Basic Scientific Research Program of Shanghai City (No.04BA05). We would like to thank the studies center of Xin Hua Hospital for providing technical assistance and professor Hong-Sheng Zhu for critical reading of the manuscript. References 1. Vaupel P, Kallinowski F, Okunieff P: Blood
flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989, 49: 6449–6465.PubMed 2. Fan LF, Diao LM: Effect of Hypoxia Induced Factor-1a on the Growth TSA HDAC of A549 lung cancer cells. J Pract Med 2007, 23: 451–453. 3. Semenza GL, Wang GL: A nuclear GS-4997 nmr factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12: 5447–5454.PubMed 4. Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995, 92: 5510–5514.CrossRefPubMed 5. Maxwell PH, Pugh CW, Ratcliffe PJ: Activation of the HIF pathway in cancer. Curr Opin Genet Dev 2001, 11: 293–299.CrossRefPubMed 6. Ji FY, Qian GS, Huang A-1210477 mw GJ: Research advance on molecular and cellular biology of small cell lung cancer. Ai Zheng 2005, 24: 903–908.PubMed 7. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270: 467–470.CrossRefPubMed 8. Jiang M, Wang B, Wang C, He B, Fan H, Shao Q, Gao
L, Liu Y, Yan G, Pu J: In vivo enhancement of angiogenesis by adenoviral transfer of HIF-1alpha-modified endothelial progenitor cells (Ad-HIF-1alpha-modified EPC for angiogenesis). Int J Biochem Cell Biol 2008, 40: 2284–2295.CrossRefPubMed 9. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, next Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999, 59: 5830–5835.PubMed 10. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G: Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000, 60: 4693–4696.PubMed 11. Lucchi M, Mussi A, Fontanini G, Faviana P, Ribechini A, Angeletti CA: Small cell lung carcinoma (SCLC): the angiogenic phenomenon. European Journal of Cardio-thoracic Surgery 2002, 21: 1105–1110.CrossRefPubMed 12.